Screening Libraries of Drug Building Blocks

  • ChemPubSoc Europe Logo
  • Author: Joseph D. Unsay
  • Published Date: 22 July 2017
  • Source / Publisher: Chemistry – A European Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Screening Libraries of Drug Building Blocks

Related Societies

DNA-encoded chemical library (DEL) technology is based on the conjugation of molecules to DNA, which then serves as a kind of identification barcode. DELs can have either a single pharmacophore per DNA strand or use a dual pharmacophore model with two complementary strands, each having their own building blocks. The latter enables self-assembly and the formation of combinatorial libraries. These libraries are also called encoded self-assembling chemical (ESAC) libraries. They facilitate the large-scale screening of protein binders (e.g., compounds that bind to kinases, proteases, and phosphatases), which could eventually result in new drug leads.


Dario Neri, Swiss Federal Institute of Technology (ETH) Zurich, Martin Mattarella, Philochem AG, Otelfingen, Switzerland, and colleagues have constructed an ESAC library with almost 150,000 members generated through the self-assembly of two sub-libraries. The researchers used the library to screen for covalent JNK1 binders. JNK1 is a kinase that regulates various cellular processes such as proliferation and transcription. The team found a synergistic effect between two building blocks labeled A82 (pictured red) and B272 ( pictured blue) and then verified the activity of these building blocks using mass spectrometry.


The team showed that individual building blocks did not form adducts with JNK1. In contrast, when the two building blocks are covalently linked (A82-L-B272), they form 1:1 adducts with JNK1 with an apparent dissociation constant of 1 µM. The researchers also showed that A82-L-B272 did not interact with other kinases, and thus, is selective against JNK1. In summary, the researchers showed that ESAC libraries could make it easier to discover ligands for proteins of pharmaceutical interest.


 

Article Views: 787

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH